BONOMI, EMANUELE MARIA
 Distribuzione geografica
Continente #
NA - Nord America 141
AS - Asia 109
EU - Europa 82
SA - Sud America 9
AF - Africa 6
Totale 347
Nazione #
US - Stati Uniti d'America 139
SG - Singapore 36
CN - Cina 33
IE - Irlanda 23
HK - Hong Kong 15
DE - Germania 11
RU - Federazione Russa 11
IT - Italia 10
VN - Vietnam 10
FI - Finlandia 8
BR - Brasile 7
IN - India 6
ZA - Sudafrica 5
GB - Regno Unito 4
FR - Francia 3
BD - Bangladesh 2
BE - Belgio 2
NL - Olanda 2
SE - Svezia 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CA - Canada 1
CL - Cile 1
EC - Ecuador 1
ES - Italia 1
HN - Honduras 1
IQ - Iraq 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
LT - Lituania 1
LV - Lettonia 1
MY - Malesia 1
PK - Pakistan 1
UA - Ucraina 1
Totale 347
Città #
Dublin 23
Singapore 21
Chandler 16
Hong Kong 15
Ashburn 14
San Jose 13
Beijing 11
Dallas 8
Munich 8
Hanoi 6
Ann Arbor 5
Johannesburg 5
Milan 5
Boardman 4
Jacksonville 4
Lawrence 4
Los Angeles 4
Medford 4
Nanjing 4
Princeton 4
Turku 4
Dearborn 3
Lauterbourg 3
Moscow 3
New York 3
Shanghai 3
Wilmington 3
Bologna 2
Brooklyn 2
Brussels 2
Chennai 2
Fremont 2
Helsinki 2
Ho Chi Minh City 2
Houston 2
Poplar 2
Tianjin 2
Woodbridge 2
Ahmedabad 1
Annapolis 1
Atlanta 1
Bandar Seri Begawan 1
Beirut 1
Bishkek 1
Buffalo 1
Cambridge 1
Campina Grande do Sul 1
Chicago 1
Cupertino 1
Cyberjaya 1
Da Nang 1
Delhi 1
Denver 1
Des Moines 1
Dimāpur 1
Erbil 1
Falkenstein 1
Frankfurt am Main 1
Guayaquil 1
Haiphong 1
Haripur 1
Hebei 1
Jiaxing 1
Langfang 1
Maceió 1
Malappuram 1
Minsk 1
Nairobi 1
Nanchang 1
Nova Erechim 1
Nuremberg 1
Providence 1
Rancharia 1
Redondo Beach 1
Riga 1
Rio de Janeiro 1
Rutherford 1
San Pedro Sula 1
Santa Clara 1
Santiago 1
Shrewsbury 1
Sofia 1
Songpa-gu 1
Sumaré 1
Taiyuan 1
Tangshan 1
Tatuí 1
Toronto 1
Totale 272
Nome #
Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial 102
Giuseppe Verdi, «Simon Boccanegra» 95
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 94
Targeted Next-Generation Sequencing Indicates a Frequent Oligogenic Involvement in Primary Ovarian Insufficiency Onset 63
Totale 354
Categoria #
all - tutte 1.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 1 0
2021/202232 0 1 0 7 1 1 1 2 2 1 3 13
2022/202354 6 7 1 2 5 3 0 1 28 0 1 0
2023/202419 7 1 0 0 2 5 1 1 0 2 0 0
2024/202574 1 5 5 4 4 4 1 5 16 1 6 22
2025/2026148 20 6 17 15 26 3 25 12 11 13 0 0
Totale 354